Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 84

1.

[Therapy resistant diabetes mellitus and lipodystrophy: leptin therapy leads to improvement].

Jazet IM, Jonker JT, Wijngaarden MA, Lamb H, Smelt AH.

Ned Tijdschr Geneeskd. 2013;157(4):A5482. Review. Dutch.

PMID:
23343738
2.

Effects of omega-3 fatty acid supplementation on mood and emotional information processing in recovered depressed individuals.

Antypa N, Smelt AH, Strengholt A, Van der Does AJ.

J Psychopharmacol. 2012 May;26(5):738-43. doi: 10.1177/0269881111424928. Epub 2011 Oct 16.

PMID:
22004690
3.

Triglycerides and gallstone formation.

Smelt AH.

Clin Chim Acta. 2010 Nov 11;411(21-22):1625-31. doi: 10.1016/j.cca.2010.08.003. Epub 2010 Aug 10. Review.

PMID:
20699090
4.

The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.

Henneman P, van der Sman-de Beer F, Moghaddam PH, Huijts P, Stalenhoef AF, Kastelein JJ, van Duijn CM, Havekes LM, Frants RR, van Dijk KW, Smelt AH.

Eur J Hum Genet. 2009 May;17(5):620-8. doi: 10.1038/ejhg.2008.202. Epub 2008 Nov 26.

5.

Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers.

Antypa N, Van der Does AJ, Smelt AH, Rogers RD.

J Psychopharmacol. 2009 Sep;23(7):831-40. doi: 10.1177/0269881108092120. Epub 2008 Jun 26.

PMID:
18583436
6.

Estrogen induced hypertriglyceridemia in an apolipoprotein AV deficient patient.

Henneman P, Schaap FG, Rensen PC, van Dijk KW, Smelt AH.

J Intern Med. 2008 Jan;263(1):107-8. No abstract available.

7.

Papillary thyroid carcinoma in a patient with sarcoidosis treated with minocycline.

Bruins NA, Oswald JE, Morreau H, Kievit J, Pavel S, Smelt AH.

Neth J Med. 2007 May;65(5):185-7.

8.

Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.

Henneman P, Schaap FG, Havekes LM, Rensen PC, Frants RR, van Tol A, Hattori H, Smelt AH, van Dijk KW.

Atherosclerosis. 2007 Jul;193(1):129-34. Epub 2006 Jun 13.

PMID:
16777114
9.

Fish oil increases bile acid synthesis in male patients with hypertriglyceridemia.

Jonkers IJ, Smelt AH, Princen HM, Kuipers F, Romijn JA, Boverhof R, Masclee AA, Stellaard F.

J Nutr. 2006 Apr;136(4):987-91.

10.

TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.

Mohrschladt MF, van der Sman-de Beer F, Hofman MK, van der Krabben M, Westendorp RG, Smelt AH.

Eur J Hum Genet. 2005 Jul;13(7):877-82.

11.

Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.

Smelt AH, de Beer F.

Semin Vasc Med. 2004 Aug;4(3):249-57. Review.

PMID:
15630634
12.

Modulating effect of the A-278C promoter polymorphism in the cholesterol 7alpha-hydroxylase gene on serum lipid levels in normolipidaemic and hypertriglyceridaemic individuals.

Hofman MK, Groenendijk M, Verkuijlen PJ, Jonkers IJ, Mohrschladt MF, Smelt AH, Princen HM.

Eur J Hum Genet. 2004 Nov;12(11):935-41.

13.

Cardiovascular disease and mortality in statin-treated patients with familial hypercholesterolemia.

Mohrschladt MF, Westendorp RG, Gevers Leuven JA, Smelt AH.

Atherosclerosis. 2004 Feb;172(2):329-35.

PMID:
15019543
14.

HDL deficiency and atherosclerosis: lessons from Tangier disease.

Hovingh GK, Kuivenhoven JA, Bisoendial RJ, Groen AK, van Dam M, van Tol A, Wellington C, Hayden MR, Smelt AH, Kastelein JJ.

J Intern Med. 2004 Feb;255(2):299-301. No abstract available.

15.

Hypertriglyceridemia: associated risks and effect of drug treatment.

Jonkers IJ, Smelt AH, van der Laarse A.

Am J Cardiovasc Drugs. 2001;1(6):455-66. Review.

PMID:
14728004
16.

Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle size.

Kuivenhoven JA, Hovingh GK, van Tol A, Jauhiainen M, Ehnholm C, Fruchart JC, Brinton EA, Otvos JD, Smelt AH, Brownlee A, Zwinderman AH, Hayden MR, Kastelein JJ.

Atherosclerosis. 2003 Dec;171(2):311-9.

PMID:
14644402
17.

Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy.

Jonkers IJ, Smelt AH, Hattori H, Scheek LM, van Gent T, de Man FH, van der Laarse A, van Tol A.

J Lipid Res. 2003 Aug;44(8):1462-9. Epub 2003 May 16.

18.

[From gene to disease; apolipoprotein E2 and familial dysbetalipoproteinemia].

Smelt AH.

Ned Tijdschr Geneeskd. 2003 Jan 25;147(4):157-9. Review. Dutch.

PMID:
12635547
19.

Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil.

Jonkers IJ, Smelt AH, Ledeboer M, Hollum ME, Biemond I, Kuipers F, Stellaard F, Boverhof R, Meinders AE, Lamers CH, Masclee AA.

Gut. 2003 Jan;52(1):109-15.

20.

Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia.

van Dam M, Zwart M, de Beer F, Smelt AH, Prins MH, Trip MD, Havekes LM, Lansberg PJ, Kastelein JJ.

Heart. 2002 Sep;88(3):234-8.

Supplemental Content

Loading ...
Support Center